Time to counter rising cardiovascular disease during pregnancy
- PMID: 36638281
- DOI: 10.1093/eurheartj/ehac770
Time to counter rising cardiovascular disease during pregnancy
Conflict of interest statement
Conflict of interest: M.G. served on an advisory board for Novartis and was a speaker for Siemens Healthcare Diagnostics. She is a co-investigator and site PI of the Women’s IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR) Study funded by the Department of Defense (award no. W81XWH-17-2-0030), and a co-investigator of the Women Ischemic Syndrome Evaluation (WISE) Study funded by the NHLBI. A.M. is supported by NIH/NCATS KL2TR003099.
Comment on
-
Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010-19.Eur Heart J. 2023 Mar 1;44(9):726-737. doi: 10.1093/eurheartj/ehac669. Eur Heart J. 2023. PMID: 36342471
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources